sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1001-1025 out of 1345.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>

Public Release: 22-Dec-2015
Lancet Infectious Diseases
Largest study of Ebola survivors finds vision, hearing, joint pain problems
The largest study of survivors of the largest recorded outbreak of Ebola virus disease found they commonly reported complications such as vision, hearing and joint pain problems up to months after they were discharged from an Ebola treatment facility.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 22-Dec-2015
PLOS Medicine
South Africa's child mortality reduction deemed 'a successful failure'
As the 25-year period for the UN Millennium Development Goals concludes on Dec. 31, 2015, to be replaced by the Sustainable Development Goals, a deeper analysis of factors outside defined goals is necessary to learn why some countries failed. This is an argument presented by researchers at Umea University in an article published today in the scientific journal PLOS Medicine.

Contact: Daniel Harju
Umea University

Public Release: 18-Dec-2015
HIV identified as leading risk factor for stroke in young African adults
HIV infection is the leading risk factor for stroke in young African adults, a new study by the University of Liverpool's Institute of Infection and Global Health has found.
Wellcome Trust, Medical Research Council, National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections

Contact: Nicola Frost
University of Liverpool

Public Release: 17-Dec-2015
Going viral: Could peroxisomes be key to stopping West Nile and Dengue viruses?
A new discovery from the University of Alberta's Faculty of Medicine & Dentistry could open the door to one day treat or prevent diseases caused by West Nile virus and Dengue virus infections. Together the viruses are the cause of tens of millions of infections each year. Currently there are no treatments or vaccines available.
Alberta Innovates: Health Solutions, Canadian Institutes of Health Research, Canada Research Chairs

Contact: Ross Neitz
University of Alberta Faculty of Medicine & Dentistry

Public Release: 17-Dec-2015
US and Mexico must work to prevent future outbreaks of mosquito-transmitted diseases
Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

Contact: Jeff Falk
Rice University

Public Release: 17-Dec-2015
La Jolla Institute for Allergy and Immunology team receives $18 million consortium grant
The La Jolla Institute for Allergy and Immunology (LJI) is pleased to announce that an international team led by LJI investigator Alessandro Sette, Ph.D., is one of four recipients of a Human Immune Profiling Consortium (HIPC) grant in 2015. With this prestigious grant, the LJI team will characterize the immune response to dengue virus (DENV) and Mycobacterium tuberculosis (TB), both of which represent major global health challenges.
National Institutes of Health

Contact: Gina Kirchweger
La Jolla Institute for Allergy and Immunology

Public Release: 17-Dec-2015
Social Science and Medicine
Top risk factors for child undernutrition in India identified
In India, nearly 40 percent of all children are stunted -- of extremely low height for their age -- and nearly 30 percent are underweight. A new study from Harvard T.H. Chan School of Public Health has now pinpointed the five top risk factors responsible for more than two-thirds of the problem.

Contact: Marge Dwyer
Harvard T.H. Chan School of Public Health

Public Release: 16-Dec-2015
$5 million in funding for research into malaria and tuberculosis drug discovery
University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly $12 million since 2012.

Contact: Heidi Singer
University of Toronto

Public Release: 15-Dec-2015
BMC Medicine
There's an app for that: An easy, fast and reliable way to record causes of death
Researchers have developed a revolutionary new app to capture accurate global cause of death data on tablets and mobile phones.

Contact: Jane Gardner
University of Melbourne

Public Release: 15-Dec-2015
PLOS Neglected Tropical Diseases
Rapid 'dipstick' test tackles fatal sleeping sickness
Scientists have developed a quick and simple diagnosis method, similar to a dipstick pregnancy test, to fight a deadly sleeping sickness. The test to diagnose Human African Trypanosomiasis (HAT) just requires a pin-prick blood sample and will remove the need to take complex equipment into remote areas of sub-Saharan Africa.
Biotechnology and Biological Sciences Research Council

Contact: Chris Melvin
Biotechnology and Biological Sciences Research Council

Public Release: 14-Dec-2015
Binghamton University professor launches web tool to track impact of drugs worldwide
Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.

Contact: Nicole Hassoun
Binghamton University

Public Release: 14-Dec-2015
Cancer Epidemiology, Biomarkers & Prevention
Cancer rates decline in many high-income countries, but rise in lower-income countries
Improved screening and detection efforts, combined with decreases in risk factors like smoking, have reduced the incidence and mortality rates from several common types of cancer in many high-income countries. However, many low- and middle-income countries have seen cancer rates rise, partially due to increases in risk factors that are typical of Western countries.
American Cancer Society

Contact: Lauren Riley
American Association for Cancer Research

Public Release: 11-Dec-2015
Researchers receive $10.2 million to study new malaria-prevention method
In collaboration with partners in Europe and Africa, researchers at Penn State have received a five-year, $10.2-million grant from the Bill & Melinda Gates Foundation to investigate a new method for preventing the transmission of malaria. The method involves limiting mosquito access to houses by blocking openings and installing 'eave tubes' that contain a unique type of insecticide-laced mosquito netting developed by Dutch partner In2Care that kills the insects as they attempt to enter.
Bill & Melinda Gates Foundation

Contact: Chuck Gill
Penn State

Public Release: 11-Dec-2015
Journal of Health Economics
AIDS treatment benefits health, economics of people without HIV, study shows
Hans-Peter Kohler of the University of Pennsylvania, along with Victoria Baranov from the University of Melbourne and Daniel Bennett from the University of Chicago, discovered that AIDS treatment can help HIV-negative people by quelling fear of the virus and boosting mental health and productivity.

Contact: Michele Berger
University of Pennsylvania

Public Release: 11-Dec-2015
Harvard, Wildlife Conservation Society launch new 'Planetary Health Alliance' with support from the Rockefeller Foundation
Today Harvard University, the Wildlife Conservation Society, and a range of other partner organizations are launching the Planetary Health Alliance, a new effort to dramatically improve our understanding of the linkages between environmental change and human health across the globe. The Planetary Health Alliance is supported by the Rockefeller Foundation, following on the recent release of the groundbreaking Rockefeller Foundation-Lancet Commission on Planetary Health, which outlines key opportunities to advance public health through more robust approaches to environmental stewardship.
Rockefeller Foundation

Contact: Samuel S. Meyers, M.D., M.P.H.
Harvard University

Public Release: 10-Dec-2015
Proceedings of the National Academy of Sciences
Scientists learn how poxviruses defeat the body's host defense
Research shows how smallpox, a feared bioterrorism agent, and other poxviruses overcome the defenses of their hosts. Implications extend to cancer therapy, said a senior author of the work, conducted at the University of Texas Health Science Center at San Antonio.

Contact: Will Sansom
University of Texas Health Science Center at San Antonio

Public Release: 10-Dec-2015
Journal of Neural Engineering
Neural stimulation offers treatment for 'dry eye'
Scientists have developed a device that electronically stimulates tear production, which will offer hope to sufferers of dry eye syndrome, one of the most common eye diseases in the world. The results are published today, Dec. 11, 2015, in the Journal of Neural Engineering.

Contact: Steve Pritchard
IOP Publishing

Public Release: 10-Dec-2015
Current Biology
Surprising diversity of TB strains found in Ethiopia
Ethiopia is a hotspot for tuberculosis (TB) infection, ranking third among African countries and eighth in the world for TB burden according to the World Health Organization. But, say researchers in Current Biology who have analyzed the genomes of 66 TB strains, that's most likely not because TB was absent in the country before Europeans made contact. Rather, Europeans may have introduced a new wave of disease spread by more virulent TB strains.

Contact: Joseph Caputo
Cell Press

Public Release: 9-Dec-2015
Mucosal Immunology
Have sex workers revealed a connection between semen exposure and HIV resistance?
In a new study, scientists at The Wistar Institute have found that continued semen exposure in these sex workers sustains changes in the cervical and vaginal microenvironment in a way that may actually increase HIV-1 resistance. This information may lead the way to better preventative strategies that block the transmission of the virus and improved designs for future HIV vaccine studies that can monitor the described changes when recruiting sex workers into vaccine trials.
National Institutes of Health, The Philadelphia Foundation, Henry S. Miller, Jr. and Kenneth Nimblett, AIDS/Commonwealth of Pennsylvania Universal Research Enhancement Program, Pennsylvania Department of Health

Contact: Ben Leach
The Wistar Institute

Public Release: 9-Dec-2015
Infection Control and Hospital Epidemiology
US capability for treating ebola outbreak appears sufficient but limited
The United States has sufficient capacity for treating another outbreak of the Ebola virus, but financial, staffing and resource challenges remain a hurdle for many hospitals and health systems attempting to maintain dedicated treatment centers for highly infectious diseases, according to new study released today. The research was published online in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).

Contact: Tamara Moore
Society for Healthcare Epidemiology of America

Public Release: 9-Dec-2015
Cell Host & Microbe
Genomic analysis sheds light on Ebola virus disease outbreak in Liberia
Scientists have performed the first comprehensive genomic analysis of Ebola virus sequences from Liberia, one of three countries widely affected by the devastating outbreak that began in 2013 in Western Africa. Their work, published today in Cell Host & Microbe, traces the introduction and spread of the virus in Liberia and also sheds light on how the virus moved between the neighboring countries of Guinea and Sierra Leone.
Defense Threat Reduction Agency, Global Biosurveillance Technology Initiative, Global Emerging Infections System, US Agency for International Development, EU Seventh Framework Programme

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 9-Dec-2015
Cell Host & Microbe
'Hijacking' and hibernating parasite could alter brain behavior
Melbourne researchers have discovered how a common parasite hijacks host cells and stockpiles food so it can lie dormant for decades, possibly changing its host's behavior or personality in the process. The findings could lead to a vaccine to protect pregnant women from Toxoplasma infection, which carries a serious risk of miscarriage or birth defects, as well as drugs to clear chronic infections in people with compromised immune systems, such as cancer patients.
National Health and Medical Research Council, Australian Research Council, veski, Human Frontiers Science Program, Victorian State Government Operational Infrastructure Support Program

Contact: Liz Williams
Walter and Eliza Hall Institute

Public Release: 9-Dec-2015
Cell Host & Microbe
How Ebola spread in Western Africa, 2014-2015
Late in 2013, a novel variant of the Ebola virus emerged in Western Africa to start what would become the largest human epidemic on record. In a study published Dec. 9th in Cell Host & Microbe, researchers used genome sequencing to find that the virus spread to Liberia multiple times from neighboring countries early during the outbreak, but the majority of Liberian cases are attributable to a single introduction of the virus.

Contact: Joseph Caputo
Cell Press

Public Release: 8-Dec-2015
PLOS Biology
Study suggests new way to help the immune system fight off sleeping sickness parasite
There are currently few treatments for African sleeping sickness, and those that exist have substantial side effects. A new study reveals a method, involving epigenetic mechanisms, that causes the African sleeping sickness parasite to change into a state that potentially makes it easier for the host immune system to eliminate.
Bill & Melinda Gates Foundation

Contact: Katherine Fenz
Rockefeller University

Public Release: 7-Dec-2015
Gates Foundation funds UMass Amherst research on deadly African cattle disease
The Bill and Melinda Gates Foundation recently announced a three-year, $478,000 grant to Samuel Black, professor of veterinary and animal sciences at the University of Massachusetts Amherst, to work with an international team developing a vaccine to control and cure trypanosomiasis, a fatal disease of cattle in sub-Saharan Africa and a major obstacle to raising livestock there.
Bill and Melinda Gates Foundation

Contact: Janet Lathrop
University of Massachusetts at Amherst

Showing releases 1001-1025 out of 1345.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>